Alpha Zero’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$655K Buy
560
+80
+17% +$81.7K 0.25% 52
2026
Q1
$441K Buy
480
+24
+5% +$24.3K 0.22% 52
2025
Q4
$490K Sell
456
-63
-12% -$60.2K 0.27% 42
2025
Q3
$396K Buy
519
+106
+26% +$78.9K 0.23% 45
2025
Q2
$322K Buy
413
+35
+9% +$27.2K 0.21% 48
2025
Q1
$312K Sell
378
-33
-8% -$27.5K 0.24% 46
2024
Q4
$317K Buy
+411
New +$340K 0.24% 52

Other funds holding LLY

Alpha Zero's LLY Position: Q2 2026 in Review

Alpha Zero increased its Eli Lilly (LLY) stake by 17% in Q2 2026, buying an estimated $81.7K and bringing the position to 560 shares worth $655K. The position accounts for 0.25% of the portfolio, ranked #52.

Alpha Zero first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 1,591 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Alpha Zero held 560 shares of Eli Lilly worth $655K as of Q2 2026.
  • Alpha Zero bought 80 Eli Lilly shares in Q2 2026, an estimated $81.7K.
  • Eli Lilly made up 0.25% of Alpha Zero's portfolio in Q2 2026, its #52 holding.
  • Alpha Zero first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 1,591 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Alpha Zero's 13F filing for Q2 2026, filed 20 Jul 2026.